TULA TUBE DELIVERY SYSTEM TDSPAP101

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 00 report with the FDA on 2013-04-11 for TULA TUBE DELIVERY SYSTEM TDSPAP101 manufactured by Acclarent, Inc..

Event Text Entries

[3277398] Acclarent was notified on (b)(6) 2013, of an event that occurred on (b)(6) 2012, during a f/u visit to an otolaryngologist at a clinic. The otolaryngologist noted that the right tympanostomy tube had medialized behind the healed tympanic membrane. The surgeon reported that the pt was asymptomatic. The pt reportedly had no ear pain and/or ear infections. However, the otolaryngologist and the family elected to remove the tube from the middle ear under general anesthesia. This was done without any adverse reaction.
Patient Sequence No: 1, Text Type: D, B5


[10718002] Acclarent followed up on this report to gather additional info. The vp of medical affairs contacted the reporting physician. The physician reported inserting the subject device with the acclarent tube delivery system on (b)(6) 2012. The procedure was said to be uneventful, and tube delivery system deployed the tube properly per the physician. The pt was seen for two or three postoperative visits over an unspecified period of time and had normalization of audiometric testing. During these visits the tympanostomy tube was observed in "normal acceptable position. " the pt later moved to another city, and several months later a different otolaryngologist noted that the right tympanostomy tube had medialized behind a healed tympanic membrane. The pt was reportedly not experiencing any pain or infections from the affected ear; however, the second otolaryngologist and the family elected to surgically remove the tube from the middle ear under general anesthesia. The pt was said to have tolerated the removal procedure well, and the status of the pt at this time is unk. Based on the info provided, it appears the tube delivery system worked appropriately, and the deployed tympanostomy tube remained in the intended position for several months. The pt's hearing issues, for which the tube was inserted, were said to have resolved. The exact cause of the reported medialization of the tympanostomy tube occurring after initial insertion is unk, but is a rare phenomenon that is referenced in literature. The rate of occurrence for this type of event does not appear to be occurring at a rate greater than expected for this type of device.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005172759-2013-00015
MDR Report Key3068091
Report Source00
Date Received2013-04-11
Date of Report2013-03-13
Date of Event2012-09-12
Date Mfgr Received2013-03-12
Device Manufacturer Date2011-11-01
Date Added to Maude2013-04-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMONICA BARRETT
Manufacturer Street1525-B O'BRIEN DR.
Manufacturer CityMENLO PARK CA 94025
Manufacturer CountryUS
Manufacturer Postal94025
Manufacturer Phone6506874948
Single Use3
Remedial ActionOT
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameTULA TUBE DELIVERY SYSTEM
Generic NameTYMPANOSTOMY TUBE DELIVERY SYSTEM
Product CodeETD
Date Received2013-04-11
Model NumberNA
Catalog NumberTDSPAP101
Lot Number111118B
ID NumberNA
Device Expiration Date2012-05-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerACCLARENT, INC.
Manufacturer AddressMENLO PARK CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2013-04-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.